Biogen, Eisai’s Leqembi Slows Alzheimer’s Progression Through 4 Years of Treatment

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the earlier stages of Alzheimer’s disease as compared to the condition’s natural progression.

Scroll to Top